Progenics

From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
http://www.progenics.com
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees


History

Controversies

Top 5 Recent Tweets

DateAuthorComment
April 20, 2021BWayynne@CoronaTurd Yeah was being generous there by limiting it to the time it was under CYDY control. Story for another d… https://t.co/H3b1h589pq
April 16, 2021ProgenicsCBWhen you choose Progenics, you can get the most out of your #cordblood. We have always successfully generated a hig… https://t.co/rTZYlEaqe8
April 07, 2021urotodayThe biology of #ProstateCancer metastasis and what #PSMAImaging is teaching us. Presentation by @pienta_brady… https://t.co/i0A8mDZR78


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history